Lupin S Goa Plant
- All
- News
-
Lupin Shares Tank 17% On USFDA's Warning Letter, Brokerages Give 'Buy' Rating
- Tuesday November 7, 2017
- Business | NDTV Profit Team
The Lupin shares crashed over 17% to trade at Rs 851 soon after it announced, in a stock filing, that it has received a warning letter issued by the USFDA pertaining to its plants located in Goa and Indore (Pithampur Unit II).
-
www.ndtv.com/business
-
Lupin Gives Up Gains On FDA Observations For Gujarat Plant
- Friday July 8, 2016
- Business | NDTV Profit Team
Shares of Lupin surged for the second day, following the US regulator's partial clearance for the drugmaker's Goa plant. Lupin shares jumped as much as 3.4 per cent to hit a high of Rs 1,712.30 today, after rising 6 per cent yesterday.
-
www.ndtv.com/business
-
Lupin Leads Selloff in Pharma Shares, Hits 52-Week Low
- Friday March 18, 2016
- Business | NDTV Profit Team
Lupin shares have been reeling under selling pressure following adverse observations about the company's Goa plant by the US Food and Drug Administration earlier this week.
-
www.ndtv.com/business
-
Lupin Shares Tank 17% On USFDA's Warning Letter, Brokerages Give 'Buy' Rating
- Tuesday November 7, 2017
- Business | NDTV Profit Team
The Lupin shares crashed over 17% to trade at Rs 851 soon after it announced, in a stock filing, that it has received a warning letter issued by the USFDA pertaining to its plants located in Goa and Indore (Pithampur Unit II).
-
www.ndtv.com/business
-
Lupin Gives Up Gains On FDA Observations For Gujarat Plant
- Friday July 8, 2016
- Business | NDTV Profit Team
Shares of Lupin surged for the second day, following the US regulator's partial clearance for the drugmaker's Goa plant. Lupin shares jumped as much as 3.4 per cent to hit a high of Rs 1,712.30 today, after rising 6 per cent yesterday.
-
www.ndtv.com/business
-
Lupin Leads Selloff in Pharma Shares, Hits 52-Week Low
- Friday March 18, 2016
- Business | NDTV Profit Team
Lupin shares have been reeling under selling pressure following adverse observations about the company's Goa plant by the US Food and Drug Administration earlier this week.
-
www.ndtv.com/business